PHARMACEUTICAL companies have been accused of making slight modifications to their drugs to extend a patent life span.
This has resulted in calls for the government to not recognise process methods for patenting, and allowing only molecular patents.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!